01Purpose and principlesWhat the assessment is for and the core concepts behind it.
Visible colour is produced by haemoglobin, melanin, dermal pigment, epidermal thickness and illumination. The same inflammatory process can look red, purple, dark brown or grey. Palpable warmth, oedema, induration, tenderness, scale and the patient’s report of change help recover signals that colour alone underestimates.
Choose anatomical sites deliberately. Oral mucosa and sclerae may reveal jaundice or central cyanosis; conjunctivae and palmar creases contribute to pallor assessment; protected skin provides a baseline for pigment. No visual sign should replace physiological measurement or relevant blood testing.
Examining skin of different pigmentation should answer a defined clinical question and be integrated with history, examination and the consequences of error. Explain uncertainty, record the sampling or observation conditions, and arrange a result-review plan rather than treating an isolated finding as self-interpreting.
Key points
- Erythema may be bright red, violaceous, grey-brown or mainly visible as swelling, warmth and surface change in deeply pigmented skin.
- Assess pallor at conjunctivae, oral mucosa, palms and nail beds, and interpret it beside symptoms and haemoglobin rather than colour impression alone.
- Look for central cyanosis at tongue and oral mucosa while checking oxygenation; peripheral nail colour is altered by temperature, perfusion, polish and pigmentation.
- Describe hyperpigmentation and hypopigmentation relative to the patient’s baseline, with distribution and texture, rather than using racial categories as proxies.
- For Examining skin of different pigmentation, describe what is seen before assigning a diagnosis, and record site, extent, symptoms, duration and change over time.
- A technically adequate result in Examining skin of different pigmentation can still be misleading when the wrong lesion, site, preparation or clinical question was selected.
02Indications, selection and cautionsWhen it is useful, when urgency changes and important limitations.
New warmth, swelling, tenderness, scale or a dusky violaceous change may identify active dermatitis or infection when bright erythema is absent.
Compare with protected and unaffected skin, ask the patient what is new, and record whether pigment is lighter, darker or depigmented.
Blue or grey tongue and oral mucosa with breathlessness, low oxygen saturation or altered consciousness requires immediate physiological assessment.
Diffuse darkening involving creases, scars and oral mucosa with weakness, weight loss or postural symptoms suggests adrenal disease.
Hyperpigmentation or hypopigmentation can remain after itch, scale and elevation resolve and may be the dominant visible consequence.
03Method and interpretationA systematic approach to the test and its findings.
Read from the initial assessment onwards. Tests may run in parallel in urgent care; first-line, preferred, confirmatory, definitive and gold-standard labels appear only when the chapter explicitly states them.
- 01
Standardised visual and tactile examinationFirst step - Why
- Identify colour, temperature, texture and elevation relative to baseline.
- Interpretation and limitations
- Use neutral lighting, compare symmetrical and protected areas, and record non-colour findings; photographs may alter hue through automatic processing.
- 02
Pulse oximetry and clinical physiology - Why
- Assess suspected cyanosis or respiratory compromise objectively.
- Interpretation and limitations
- Interpret saturation with waveform quality and context; visual cyanosis is neither sensitive nor specific enough to grade hypoxaemia.
- 03
FBC and targeted biochemical testing - Why
- Confirm suspected anaemia, bilirubin elevation or endocrine disease.
- Interpretation and limitations
- Request tests from the full syndrome rather than skin tone alone; normal appearance cannot exclude important biochemical abnormality.
- 04
Dermoscopy or Wood lamp when indicated - Why
- Clarify pigment network, vascular clues or depigmentation boundaries.
- Interpretation and limitations
- These tools supplement examination; device algorithms and photographic databases may perform unevenly across pigmentation groups.
04Clinical next stepsHow the result changes management or prompts escalation.
01Planned assessmentUse multimodal skin assessment systematicallyFirst stepThe patient is stable and the result will alter diagnosis, referral or follow-up.+
- 1Define the question for Examining skin of different pigmentation, explain the process and obtain valid consent before exposing, touching, photographing or sampling skin.
- 2Choose representative anatomy, optimise lighting or specimen technique, and document site, morphology, symptoms and relevant previous treatment. Apply that step specifically within the examining skin of different pigmentation assessment and its recorded clinical context.
- 3Interpret the result beside the full clinical pattern, communicate uncertainty and arrange ownership of results and safety-netting. Apply that step specifically within the examining skin of different pigmentation assessment and its recorded clinical context.
02Uncertain resultResolve discordance in Examining skin of different pigmentationThe technical finding conflicts with the history, lesion evolution or wider examination.+
- 1Recheck identity, site, timing, preparation, treatment exposure and whether the selected target was genuinely representative. Apply that step specifically within the examining skin of different pigmentation assessment and its recorded clinical context.
- 2Repeat or select a complementary test only when it can distinguish the remaining important alternatives. Apply that step specifically within the examining skin of different pigmentation assessment and its recorded clinical context.
- 3Seek dermatology, pathology, microbiology or allergy advice when clinicopathological disagreement would change urgent care. Apply that step specifically within the examining skin of different pigmentation assessment and its recorded clinical context.
03Urgent patternDo not let multimodal skin assessment delay escalationEscalationA rapidly progressive eruption, systemic illness, threatened vision or airway, or suspected aggressive malignancy is present. Apply that step specifically within the examining skin of different pigmentation assessment and its recorded clinical context.+
- 1Stabilise immediate physiological threats and obtain same-day senior or specialty assessment according to the dominant emergency. Apply that step specifically within the examining skin of different pigmentation assessment and its recorded clinical context.
- 2DefinitiveTake time-critical images or specimens only when doing so will not postpone resuscitation, antimicrobials or definitive referral. Apply that step specifically within the examining skin of different pigmentation assessment and its recorded clinical context.
- 3Record evolution and communicate the differential, outstanding results and explicit deterioration triggers during handover. Apply that step specifically within the examining skin of different pigmentation assessment and its recorded clinical context.
05Risks, monitoring and follow-upComplications, safety checks and further assessment.
- Record who will review the result arising from Examining skin of different pigmentation, the expected timescale and the action threshold before the patient leaves.
- Compare subsequent findings with the original site description, dimensions, symptoms and image or specimen identifiers for Examining skin of different pigmentation.
- Reassess earlier if rapid growth, bleeding, ulceration, fever, mucosal disease, eye symptoms or functional compromise develops. Apply that step specifically within the examining skin of different pigmentation assessment and its recorded clinical context.
- Document technical limitations and previous treatment that could alter sensitivity or specificity of multimodal skin assessment.
- Close the loop after specialist or laboratory review, including clinicopathological disagreement and any need for repeat sampling. Apply that step specifically within the examining skin of different pigmentation assessment and its recorded clinical context.
06Special situationsVariants, exceptions and circumstances that change the usual approach.
Ask what changed
Patients often detect altered colour or texture earlier than an examiner unfamiliar with their baseline pigmentation.
Inflammation is three-dimensional
Warmth, oedema, scale, tenderness and induration can be more conspicuous than hue and should guide severity assessment.
Pigmentary sequelae matter
Post-inflammatory dyschromia may persist longer than the initiating eruption and substantially affect wellbeing and treatment choices.
Devices inherit bias
Poor validation across skin tones can affect image algorithms and oxygen measurements, so reconcile outputs with physiology.
Language should be literal
Specific descriptors such as dark brown, grey, violaceous or lighter than baseline communicate better than vague ethnic labels.
07Common pitfallsFrequent interpretation and management errors.
- 01
Documenting no erythema when the skin is warm, swollen, tender and newly darker than the patient’s baseline.
- 02
Using nail beds alone to assess cyanosis despite cold peripheries, nail products or physiological concern.
- 03
Assuming pigmentation change is cosmetic before asking about symptoms, medicines and systemic illness.
- 04
Comparing a lesion with an external colour chart instead of the patient’s unaffected and protected skin.
- 05
Treating automated image analysis as validated equally across all pigmentation without checking its intended population.